Synthon Hispania, S.L. (production of finished dosage form, primary and secondary packaging, batch control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of men with symptoms of benign prostatic hyperplasia. It helps with frequent or urgent urges to urinate and also improves the bladder emptying process.
Dosage form: tablets, modified release
Active substance Dosage solifenacin 6 mg tamsulosin 0.4 mg ATC: G04CA53